Last update :
28/04/2024
References   References 3577  
Type : Manufacturer

Research teams :
Authors :
Title : Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
Reference : Galen Limited

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionDaunorubicin hydrochloride liposome Anticancer drug
Factors which affect stability Solvent Sodium chloride 0,9% Induces Degradation
Factors which affect stability Temperature -20°C Induces Degradation
Factors which affect stability PH PH > 8 Induces Degradation
Stability in solutions Not specified Glucose 5% 0,2 >> 1 mg/ml 25°C Not specified
6 Hour
Incompatible + Sodium chloride 0,9%
Incompatible + InjectionDexamethasone sodium phosphate
Incompatible + InjectionHeparin sodium
InjectionDexamethasone sodium phosphate Anti-inflammatory
Incompatible + InjectionDaunorubicin hydrochloride liposome
InjectionHeparin sodium Anticoagulant
Incompatible + InjectionDaunorubicin hydrochloride liposome

  Mentions Légales